Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca cervical cancer treatment fails to meet endpoint in Phase III trial

March 24, 2022
Business Services

AstraZeneca has shared that results from its Calla Phase III trial of Imfinzi for the treatment of locally advanced cervical …

News

Spot the Difference: A Common Cold, or COVID-19?

March 24, 2022

Prior to the pandemic, if you got a runny nose and a sore throat, you would likely assume it was …

News

Novel therapy could revolutionise treatment for asthma, COPD, among others

March 24, 2022
Business Services

A multicenter research team in Texas has developed the first drug to treat the uncontrolled secretion of mucins in the …

News

FDA approval for castration-resistant prostate cancer

March 24, 2022
Business Services

The FDA has approved Novartis’ prostate cancer treatment, Pluvicto™, which is now expected to become available in a few weeks. …

News

Study finds COVID-19 may double severe complications in pregnancy

March 23, 2022
Research and Development

A Kaiser Permanente analysis of pregnant patients who tested positive for COVID-19 found more than double the risk of severe …

News

Alnylam sues Moderna and Pfizer over key vaccine ingredient

March 23, 2022
Research and Development

Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based company, has sued Moderna and Pfizer over allegations that the firms used patented nanoparticle technology …

News

ONS says no evidence that COVID-19 vaccines lead to young deaths

March 23, 2022
Research and Development

The Office for National Statistics (ONS) has said that there is no evidence that COVID-19 vaccines have led to an …

News

Pfizer to supply UNICEF oral COVID-19 treatment for low- and middle-income countries

March 23, 2022
Research and Development

Pfizer have announced the signing of a supply agreement with the United Nations Children’s Fund (UNICEF), to deliver up to …

News

FDA approval for first drug for rare form of epilepsy

March 22, 2022
Manufacturing and Production

Those living in the US with CDKL5 deficiency disorder, or CDD, may now have access to the first FDA-approved treatment …

News

MDMA improves PTSD symptoms, study finds

March 22, 2022
Manufacturing and Production

In findings presented at the American Chemical Society’s (ACS) Spring Meeting for 2022, researchers reported on follow-up results form a …

News

Pfizer recalls blood pressure drug due to potential carcinogen

March 22, 2022
Manufacturing and Production

Pfizer is voluntarily recalling certain hypertension medications due to the potential presence of impurities. The affected products have been distributed …

News
hand

Collaboration to offer heart rhythm checks to detect atrial fibrillation

March 22, 2022
Manufacturing and Production

Daiichi Sankyo and O’Brien’s Pharmacies Group have today announced the launch of a collaboration in North West England to offer …

News
guy_photo_2022_002

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

March 21, 2022
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …

Appointment

FDA approval for first in class immunotherapy for advanced melanoma

March 21, 2022
Sales and Marketing

The FDA has approved Bristol-Myers Squibb’s Opdualag (nivolumab and relatlimab-rmbw), the first drug in a new class of cancer immunotherapies, …

News

Spring COVID-19 booster launches for over-75s and high risk in England

March 21, 2022
Sales and Marketing

Those aged 75 and over, alongside residents in care homes and those with weakened immune systems, can now book an …

News

UCLA’s HIV prevention and treatment centre receives $7.5 million NIH grant

March 21, 2022
Sales and Marketing

The National Institute of Mental Health has renewed its support for UCLA’s collaborative Centre for HIV Identification, Prevention and Treatment …

News

Merck’s Keytruda delivers reduced risk of death in adjuvant NSCLC

March 21, 2022
Sales and Marketing

Merck has announced positive results from its Phase III trial into Keytruda for non-small cell lung cancer. The KEYNOTE-091 study …

News
moderna_norwood_plant

Moderna seeks FDA authorisation for fourth COVID-19 jab for adults

March 18, 2022
Medical Communications

Moderna has requested an EUA from the FDA for a fourth dose of its COVID-19 vaccine, as a booster for …

News

NIH fund research for Short Bowel Syndrome

March 18, 2022
Medical Communications

A Saint Louis University School of Medicine physician-scientist has received funding of $428,020, from the National Institutes of Allergy and …

News

GSK halts new clinical trials in Russia

March 18, 2022
Medical Communications

Britain’s second biggest drugmaker, GlaxoSmithKline (GSK), has joined other pharmaceutical companies including Pfizer, sharing that it will not start clinical …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025